![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Mallinckrodt Inc St Louis Us, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Desmopressin, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2000-060 - Rev 01
This Chemical Type CEP, issued on November 22, 2004, remains in force until January 31, 2008, ensuring its reliability within the pharmaceutical industry.
Substance Number 712 associated with this CEP further emphasizes